Researchers at Munich's Max Planck Institute for Psychiatry showed that mutations in the ABCB-1 gene affect how three widely used antidepressants work – or don't work, reports this Reuters article. Using mice genetically engineered to lack this gene, they found the gene and the protein blocked Celexa and Effexor but not Remeron.